🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
This study will assess the safety, efficacy and immune response following t...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-03-22
Trial ID
NCT05276297
Treatments Being Tested
This is an open-label study to determine the efficacy, safety, tolerability...
Status
Completed
Location
Prince Of Wales Hospital
Start Date
2022-09-21
Trial ID
NCT05343481
Treatments Being Tested
This is an open-label study to determine the safety, tolerability and immun...
Status
Completed
Location
Pusan National University Hospital
Start Date
2020-12-22
Trial ID
NCT04778904
Treatments Being Tested
A First-Time-In-Human study on GSK's therapeutic vaccines to evaluate the r...
Status
Terminated
Location
GSK Investigational Site
Start Date
2019-03-28
Trial ID
NCT03866187
This study is an open-label, ascending dose phase 1b/2a trial to assess the...
Status
Recruiting
Location
Investigational Site GUF
Start Date
2025-06-12
Trial ID
NCT06513286
Treatments Being Tested
This study is an open-label, ascending dose phase 1a trial to assess the sa...
Status
Completed
Location
Bernhard Nocht Centre for Clinical Trials (BNCCT)
Start Date
2024-01-23
Trial ID
NCT05727267
Treatments Being Tested